Results 131 to 140 of about 883,314 (350)

Management of cardiogenic shock complicating myocardial infarction: an update 2019.

European Heart Journal, 2019
Cardiogenic shock (CS) remains the most common cause of death in patients admitted with acute myocardial infarction (AMI) and mortality remained nearly unchanged in the range of 40-50% during the last two decades.
H. Thiele, E. Ohman, S. de Waha‐Thiele, U. Zeymer, S. Desch   +4 more
semanticscholar   +1 more source

An unusual presentation of pheochromocytoma accompanied by catecholamine‐induced cardiomyopathy

ESC Heart Failure, EarlyView.
Hugh O.J. Roberts, Alexandru Munteanu, Jonas E. Mertens   +2 more
wiley   +1 more source

Clinical characteristics and outcomes of adults with acute heart failure in a South African teaching hospital

ESC Heart Failure, EarlyView.
In this study of 406 adults admitted with acute heart failure, the overall in‐hospital mortality rate was 3.4%. Independent predictors of in‐hospital mortality included elevated neutrophil‐lymphocyte ratio, C‐reactive protein, and potassium levels, along with moderate or severe aortic regurgitation and lower diastolic blood pressure.
Umar G. Adamu, Muzi Maseko, Nqoba Tsabedze   +2 more
wiley   +1 more source

Treatment of heart failure related cardiogenic shock: Time to fill the evidence gap. [PDF]

ESC Heart Fail
ESC Heart Failure, Volume 12, Issue 4, Page 2401-2403, August 2025.
Pöss J, Freund A, Thiele H.
europepmc   +2 more sources

Remote pulmonary artery pressure‐guided management of patients with heart failure: A clinical consensus statement of the Heart Failure Association (HFA) of the ESC

European Journal of Heart Failure, EarlyView.
Abstract Episodes of worsening heart failure (HF) are a major cause of unplanned hospitalizations. Their onset is usually preceded by an early increase in intracardiac pressures with subsequent worsening of symptoms due to congestion. Implantable devices allowing daily remote pulmonary artery pressure (PAP) monitoring are useful to identify early ...
Antoni Bayes‐Genis, Matteo Pagnesi, Pau Codina, William T. Abraham, Offer Amir, Rudolf A. de Boer, Jasper J. Brugts, Ovidiu Chioncel, Finn Gustafsson, JoAnn Lindenfeld, Wilfried Mullens, Mark C. Petrie, Giuseppe Rosano, Marco Metra   +13 more
wiley   +1 more source

Hemodynamic Studies in Cardiogenic Shock [PDF]

, 1967
H.-J. Smith, A Oriol, J E Morch, M. McGregor   +3 more
openalex   +1 more source

Long-Term Outcomes of Cardiogenic Shock Complicating Myocardial Infarction.

Journal of the American College of Cardiology, 2023
Lee H. Sterling, S. Fernando, R. Talarico, Danial Qureshi, Sean van Diepen, M. Herridge, S. Price, D. Brodie, E. Fan, P. Di Santo, Richard G. Jung, S. Parlow, M. Basir, D. Scales, A. Combes, Rebecca Mathew, H. Thiele, P. Tanuseputro, B. Hibbert   +18 more
semanticscholar   +1 more source

Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock: Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis

Circulation, 2019
Background: Percutaneous mechanical circulatory support devices are increasingly used in acute myocardial infarction complicated by cardiogenic shock (AMI-CS), despite limited evidence for their effectiveness.
B. Schrage, K. Ibrahim, T. Loehn, N. Werner, J. Sinning, F. Pappalardo, M. Pieri, Carsten Skurk, A. Lauten, U. Landmesser, R. Westenfeld, P. Horn, M. Pauschinger, D. Eckner, R. Twerenbold, P. Nordbeck, T. Salinger, P. Abel, K. Empen, M. Busch, S. Felix, J. Sieweke, J. Møller, N. Pareek, J. Hill, P. MacCarthy, M. Bergmann, J. Henriques, S. Möbius‐Winkler, P. C. Schulze, T. Ouarrak, U. Zeymer, S. Schneider, S. Blankenberg, H. Thiele, A. Schäfer, D. Westermann   +36 more
semanticscholar   +1 more source

Mitochondrial targets in ischaemic heart disease and heart failure, and their potential for a more efficient clinical translation. A scientific statement of the ESC Working Group on Cellular Biology of the Heart and the ESC Working Group on Myocardial Function

European Journal of Heart Failure, EarlyView.
Improving clinical translation of mitoprotective therapies. 31P MRI, phosphorus‐31 magnetic resonance imaging; hiPSC‐CM, human‐induced pluripotent stem cell‐derived cardiomyocyte; IHD, ischaemic heart disease. Abstract Acute myocardial infarction (MI) remains a major cause of death and disability worldwide.
Melanie Paillard, Mahmoud Abdellatif, Ioanna Andreadou, Christian Bär, Luc Bertrand, Bianca J.J.M. Brundel, Gemma Chiva‐Blanch, Sean M. Davidson, Dana Dawson, Fabio Di Lisa, Paul Evans, Zoltan Giricz, Derek J. Hausenloy, Petra Kleinbongard, Frank Lezoualc'h, Elisa Liehn, Christoph Maack, Ange Maguy, Elizabeth Murphy, Cinzia Perrino, Maurizio Pesce, Peter P. Rainer, Katrin Streckfuss‐Bömeke, Matthias Thielmann, Rong Tian, Carlo G. Tocchetti, Jolanda Van Der Velden, Sophie Van Linthout, Serena Zacchigna, Thomas Krieg   +29 more
wiley   +1 more source

Refractory cardiogenic shock in hypertrophic cardiomyopathy complicated by apical ballooning: A case report

Journal of International Medical Research
Hypertrophic cardiomyopathy can be accompanied by dynamic obstruction in the left ventricular outflow tract and acute apical ballooning, which are among the very rare causes of cardiogenic shock. This condition requires a specific treatment approach that
Matej Strycek, Rostislav Polasek, Pavol Tomasov, Jiri Karasek   +3 more
doaj   +1 more source